Award
National Institute of Allergy and Infectious Diseases 5R01AI162151-05
Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention
Recipient
Not specified
Award Amount
$726,042.00
Ceiling
$726,042.00
Awarded
August 15, 2025
Identifier
5R01AI162151-05
This award supports the development of a long-acting implant for HIV prevention, including design, safety, pharmacokinetics, and efficacy testing in primates, under NIH's HIV prevention initiatives.
Description
The project aims to develop a long-acting implant for HIV prophylaxis, building on previous NIH-supported research. The project includes designing a next-generation implant, conducting pharmacokinetic and safety studies, and testing efficacy in non-human primates. The award is part of NIH's efforts to improve HIV prevention strategies through sustained-release drug delivery systems.